When an aesthetic practice hires a new injector — whether an RN, NP, PA, or physician — the first day of patient contact should not be the first day the practice has verified that injector can safely treat. Every delegation framework, every standing order, and every malpractice defense rests on one document the practice either has or does not: the injector's onboarding credentialing file.
This is not a personnel folder. It is a clinical governance record that answers three questions: What is this provider authorized to do? Who verified that they can do it safely? When was that authorization last reviewed?
What Belongs in the Onboarding File
The onboarding file is a structured collection of documents that together establish the injector's scope of practice within this specific clinic. It should contain the following sections.
Licensure and Identity
- Copy of current state professional license (RN, NP, PA, MD/DO).
- DEA registration if the provider prescribes controlled substances.
- State-specific requirements: collaborative practice agreement (for NPs in restricted-practice states), supervisory protocols, or registration with the state medical board.
- Government-issued photo ID.
- Malpractice insurance certificate naming the practice as additionally insured.
Every license expiration date should be logged in a tracking system. Lapsed licensure discovered after an adverse event converts a clinical issue into a regulatory one.
Training and Certification Documentation
There is no federal "Botox certification." The authority to inject comes from the professional license and state scope-of-practice law. But the standard of care — and the expectation of malpractice insurers, employers, and medical directors — requires documented training in facial anatomy, injection technique, patient assessment, and complication management.
The file should include:
- Certificates of completion from accredited injectable training programs. The Plastic Surgical Nursing Certification Board (PSNCB) offers the Certified Aesthetic Nurse Specialist (CANS) credential, which requires documented clinical hours and a passing exam score. This is voluntary but strengthens the file.
- CME or CE credit transcripts from aesthetic medicine courses.
- Records of supervised clinical hours during training, including the number and type of cases.
- Competency assessments from training instructors.
- Cadaver lab attendance records (relevant for advanced facial anatomy training).
- Device-specific training certificates for any energy-based devices or specialized injection techniques the injector will use.
Privileging Grid
The core of the onboarding file is a privileging grid: a document that lists every procedure the injector is authorized to perform, at what level of supervision, and with what date of authorization.
A sample grid structure:
| Procedure | Supervision Level | Authorized Date | Competency Method | Next Review |
|---|---|---|---|---|
| Neuromodulator injection — glabella, forehead, crow's feet | Direct (on-site physician) | 2026-03-15 | Observed 10 cases, medical director sign-off | 2026-09-15 |
| HA filler injection — nasolabial folds, lips | Direct | 2026-04-01 | Observed 8 cases, complication scenario drill passed | 2026-10-01 |
| HA filler injection — tear troughs, nose | Prohibited until Level 2 | — | — | — |
| Cannula technique — midface | Indirect (physician available by phone) | 2026-05-01 | 5 supervised cases, chart review | 2026-11-01 |
| Laser hair removal — all Fitzpatrick | Indirect | 2026-03-20 | Device manufacturer training + 20 supervised treatments | 2026-09-20 |
Supervision levels should align with state law. In many states, RNs require direct physician supervision for injections; NPs may practice independently or under collaborative agreements depending on the jurisdiction. The grid is a practice-level document that should be more restrictive than state law — never less.
Competency Assessment: How Practices Verify Skill
Competency cannot be documented by a training certificate alone. A certificate proves the injector attended a course. It does not prove the injector can safely treat patients in your clinic, with your products, under your protocols.
Competency assessment has four stages:
Stage 1: Didactic Review
The injector completes the practice's written training modules covering:
- Facial anatomy relevant to injection sites — muscle layers, vascular territories (angular artery, supraorbital, supratrochlear, ophthalmic), and danger zones.
- Product pharmacology for every neuromodulator and filler the practice carries, including FDA-approved indications, off-label use documentation, and contraindications.
- Injection technique fundamentals: needle vs. cannula selection, bolus vs. serial micro-puncture, aspiration, depth planes.
- The practice's standing orders and delegation agreement.
A written assessment at the end of this stage documents baseline knowledge.
Stage 2: Supervised Clinical Practice
The injector treats patients under direct supervision of the medical director or a senior injector with documented competency. The number of supervised cases varies by procedure risk level:
- Low-risk neuromodulator sites (forehead, glabella, crow's feet): minimum 5–10 observed cases.
- Mid-risk HA filler sites (nasolabial folds, marionette lines, lips): minimum 8–10 observed cases.
- High-risk sites (tear troughs, nose, temporal region): minimum 10–15 observed cases, often with a separate competency sign-off and sometimes requiring advanced training or cadaver lab completion.
The supervising provider documents each observed case: patient selection, injection technique, product and dose, adverse event management, and communication with the patient.
Stage 3: Emergency Protocol Verification
Before independent injection privileges are granted, the injector must demonstrate competency in emergency response. This is where many onboarding processes fail — the injector is competent to inject but not to manage a vascular occlusion or anaphylactic reaction.
Verification includes:
- Written or verbal exam on the practice's vascular occlusion protocol: recognition signs (blanching, livedo reticularis, delayed capillary refill, pain out of proportion), hyaluronidase dosing, escalation pathway, and documentation requirements.
- Observed or simulated anaphylaxis response: epinephrine administration, airway management, 911 activation protocol.
- Location and contents of the practice's emergency kit documented by the injector.
Stage 4: Medical Director Sign-Off
The medical director reviews the completed file — licensure, training, competency assessments, emergency verification — and signs a privileging authorization document. This document specifies:
- The procedures the injector is authorized to perform.
- The required supervision level for each.
- Any restrictions (e.g., "no nasal filler until 20 additional supervised cases completed").
- The date the privileges take effect.
- The review schedule.
This sign-off is not a formality. It is the medical director's affirmative clinical judgment that this injector can safely treat patients under the practice's delegation framework. In a board complaint or malpractice action, the question will be: did the medical director conduct a meaningful competency evaluation, or did they sign without review?
The Continuing Review Cycle
Privileging is not a one-time event. A defensible credentialing file requires scheduled reviews.
90-Day Review
For new injectors, a 90-day review after initial privileging covers:
- Chart audit of a sample of treated patients (minimum 10 charts), checking documentation completeness, appropriate product and dose selection, and follow-up documentation.
- Adverse event log review: every complication, even minor ones, with documentation of management and outcome.
- Patient feedback review.
- Direct observation of at least one treatment session by the medical director.
Annual Re-Privileging
Every injector — regardless of experience level — should undergo annual re-privileging that includes:
- License and insurance renewal verification.
- Continuing education documentation (minimum hours per state requirements; the practice may set a higher bar).
- Chart audit: random sample of charts reviewed against the practice's documentation standards.
- Adverse event trend review: has this injector's complication rate changed?
- Updated privileging grid reflecting any new procedures, technique changes, or supervision level changes.
- Medical director sign-off on continued authorization.
Triggered Review
Certain events should trigger an immediate file review outside the scheduled cycle:
- A serious adverse event (vascular occlusion, infection requiring intervention, allergic reaction requiring emergency response).
- A patient complaint filed with the state board.
- A change in the injector's licensure status.
- A change in the practice's standing orders or delegation framework.
- The injector requests privileges for a new procedure.
Common Onboarding Failures
Practices that have faced board complaints or malpractice claims after an injector error share these patterns:
- No written competency assessment. The injector was "trained on the job" with no documented evaluation of skill.
- No privileging grid. The practice could not show what the injector was and was not authorized to do.
- No emergency protocol verification. The injector had never drilled a vascular occlusion response.
- No chart audit schedule. The first time anyone reviewed the injector's documentation was after a complaint.
- Stale file. The onboarding file had not been updated since the hire date, sometimes years earlier.
- Missing delegation agreement. The injector had no documented delegation agreement linking their work to the supervising physician's authority.
Each of these failures is preventable with the structure described above. The credentialing file is the practice's evidence that clinical governance existed before something went wrong — not a document assembled after the fact.
Sources
- American Society for Dermatologic Surgery, "Consensus Statement Regarding Storage and Reuse of Previously Reconstituted Neuromodulators" (ASDS, 2015, reaffirmed 2024): https://www.asds.net/Portals/0/PDF/asdsa/white-paper-storage-and-reuse-of-reconstituted-neuromodulators.pdf
- American Academy of Ophthalmology, "Functional Botox Treatments — Quick Tips for Documentation and Coding": https://www.aao.org/eyenet/article/functional-botox-treatments-documentation-coding
- IAPAM, "Botox Certification by State: A Complete Regulatory Guide (2026)": https://iapam.com/botox-library/botox-certification-by-state
- PNA Aesthetics Academy, "Medical Director Training — Module 6: Training, Supervision & Provider Development": https://pnaestheticsacademy.com/medical-director-training
- Plastic Surgical Nursing Certification Board (PSNCB), CANS Certification Requirements: https://psncb.org
- APT Injection Training, "Setting Up a Med Spa — The Role of the Medical Director and Your Compliance Checklist": https://aptinjectiontraining.com/blog/setting-up-a-med-spa-the-role-of-the-medical-director-and-your-compliance-checklist
- American Med Spa Association, "Med Spa Laws State by State": https://www.americanmedspa.org/med-spa-laws




